Skip to content
10-Q

Quarterly Report

Thorne HealthTech, Inc.

0000950170-23-021489

← back to feed
Filed
May 12, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 11, 2023 53.86M sh
Shares Diluted Q1 2023 · Mar 31, 2023 53.34M sh
Shares Diluted Q1 2023 · Mar 31, 2022 52.62M sh
Capex Q1 2023 · Mar 31, 2023 $13.17M
Capex Q1 2023 · Mar 31, 2022 $1.49M
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$5.73M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$4.5M
Long Term Debt Q1 2023 · Mar 31, 2023 $13.7M
Long Term Debt Q1 2023 · Dec 31, 2022 $12.65M
Short Term Debt Q1 2023 · Mar 31, 2023 $787.43K
Short Term Debt Q1 2023 · Dec 31, 2022 $523.51K
Cash And Equivalents Q1 2023 · Mar 31, 2023 $11.06M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $36.02M
Stockholders Equity Q1 2023 · Mar 31, 2023 $147.41M
Stockholders Equity Q1 2023 · Dec 31, 2022 $144.99M
Current Liabilities Q1 2023 · Mar 31, 2023 $31.91M
Current Liabilities Q1 2023 · Dec 31, 2022 $39.56M
Total Liabilities Q1 2023 · Mar 31, 2023 $91.91M
Total Liabilities Q1 2023 · Dec 31, 2022 $83.15M
Current Assets Q1 2023 · Mar 31, 2023 $115.38M
Current Assets Q1 2023 · Dec 31, 2022 $116.62M
Total Assets Q1 2023 · Mar 31, 2023 $240.85M
Total Assets Q1 2023 · Dec 31, 2022 $229.8M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.01
Eps Diluted Q1 2023 · Mar 31, 2022 $0.09
Eps Basic Q1 2023 · Mar 31, 2023 −$0.01
Eps Basic Q1 2023 · Mar 31, 2022 $0.09
Sga Expense Q1 2023 · Mar 31, 2023 $23.58M
Sga Expense restated Q1 2023 · Mar 31, 2022 $17.93M
Rd Expense Q1 2023 · Mar 31, 2023 $1.77M
Rd Expense Q1 2023 · Mar 31, 2022 $1.97M
Net Income Q1 2023 · Mar 31, 2023 −$402.16K
Net Income Q1 2023 · Mar 31, 2022 $4.98M
Operating Income Q1 2023 · Mar 31, 2023 −$14.73K
Operating Income Q1 2023 · Mar 31, 2022 $4.78M
Gross Profit Q1 2023 · Mar 31, 2023 $34.27M
Gross Profit restated Q1 2023 · Mar 31, 2022 $29.48M
Cost Of Revenue Q1 2023 · Mar 31, 2023 $30.96M
Cost Of Revenue Q1 2023 · Mar 31, 2022 $24.55M
Revenue Q1 2023 · Mar 31, 2023 $65.24M
Revenue restated Q1 2023 · Mar 31, 2022 $54.03M